SEC Form 4 · accession 0001179110-18-001638
Strongbridge Biopharma plc · SBBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Pauls
Officer — President & CEO · Director
Period of report
Feb 5, 2018
Accepted (ET)
Feb 6, 2018 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001634432
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.65 | Feb 5, 2018 | A | 350,000 | A | — | Feb 5, 2028 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1This option vests in sixteen equal quarterly installments beginning May 5, 2018, provided employee is employed by the Company on each vesting date.